Typicality: | 0.250 |
Saliency: | 0.000 |
in an in vitro study | 2 | location |
naproxen → inhibit → platelet aggregation | 3 |
negative | neutral | positive |
0.482 | 0.490 | 0.028 |
Raw frequency | 3 |
Normalized frequency | 0.000 |
Modifier score | 0.500 |
Perplexity | 68.311 |